BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21044987)

  • 1. Neuropharmacology of addiction and how it informs treatment.
    Lingford-Hughes A; Watson B; Kalk N; Reid A
    Br Med Bull; 2010; 96():93-110. PubMed ID: 21044987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacology of addiction--setting the scene.
    Lawrence AJ; Beart PM; Kalivas PW
    Br J Pharmacol; 2008 May; 154(2):259-60. PubMed ID: 18414384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Principles of the pharmacological treatment of drug addiction].
    Saadan M; Scuvée-Moreau J; Seutin V
    Rev Med Liege; 2013; 68(5-6):245-51. PubMed ID: 23888572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of addiction and implications for treatment.
    Lingford-Hughes A; Nutt D
    Br J Psychiatry; 2003 Feb; 182():97-100. PubMed ID: 12562734
    [No Abstract]   [Full Text] [Related]  

  • 5. From neurobiology to treatment: progress against addiction.
    Nestler EJ
    Nat Neurosci; 2002 Nov; 5 Suppl():1076-9. PubMed ID: 12403990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
    Gawin FH
    J Clin Psychiatry; 1988 Feb; 49 Suppl():11-6. PubMed ID: 3276669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dependence: neuropharmacology and management.
    Deslandes PN; Pache DM; Sewell RD
    J Pharm Pharmacol; 2002 Jul; 54(7):885-95. PubMed ID: 12162706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral monoamine neurotransmitters in opioid withdrawal and dependence.
    Ahtee L; Attila LM
    Med Biol; 1987; 65(2-3):113-9. PubMed ID: 2888928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addiction and withdrawal--current views.
    Melichar JK; Daglish MR; Nutt DJ
    Curr Opin Pharmacol; 2001 Feb; 1(1):84-90. PubMed ID: 11712541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
    Verrico CD; Haile CN; Newton TF; Kosten TR; De La Garza R
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1549-68. PubMed ID: 24033127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurocircuitry of addiction: an overview.
    Feltenstein MW; See RE
    Br J Pharmacol; 2008 May; 154(2):261-74. PubMed ID: 18311189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants].
    Herz A
    Nervenarzt; 1995 Jan; 66(1):3-14. PubMed ID: 7885510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug abuse: hedonic homeostatic dysregulation.
    Koob GF; Le Moal M
    Science; 1997 Oct; 278(5335):52-8. PubMed ID: 9311926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
    Jentsch JD; Roth RH; Taylor JR
    Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinases and addiction.
    Lee AM; Messing RO
    Ann N Y Acad Sci; 2008 Oct; 1141():22-57. PubMed ID: 18991950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions.
    Chamberlain SR; Grant JE
    Neuropsychol Rev; 2019 Mar; 29(1):93-102. PubMed ID: 30852805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The debate over dopamine's role in reward: the case for incentive salience.
    Berridge KC
    Psychopharmacology (Berl); 2007 Apr; 191(3):391-431. PubMed ID: 17072591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug addiction and brain targets: from preclinical research to pharmacotherapy.
    Rahman S
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):391-2. PubMed ID: 19128198
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.